Osborn Williams & Donohoe’s Kindred Biosciences, Inc. KIN Stock Holding History

Osborn Williams & Donohoe’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$251K	Hold	62,700	–	–	0.03%	236
2019 Q4	$532K	Hold	62,700	–	–	0.05%	223
2019 Q3	$429K	Hold	62,700	–	–	0.04%	234
2019 Q2	$522K	Hold	62,700	–	–	0.05%	220
2019 Q1	$561K	Hold	62,700	–	–	0.06%	234
2018 Q4	$687K	Hold	62,700	–	–	0.12%	140
2018 Q3	$875K	Hold	62,700	–	–	0.14%	133
2018 Q2	$668K	Hold	62,700	–	–	0.11%	143
2018 Q1	$542K	Hold	62,700	–	–	0.09%	155
2017 Q4	$593K	Hold	62,700	–	–	0.1%	148
2017 Q3	$492K	Hold	62,700	–	–	0.09%	158
2017 Q2	$539K	Hold	62,700	–	–	0.1%	151
2017 Q1	$442K	Hold	62,700	–	–	0.08%	163
2016 Q4	$266K	Hold	62,700	–	–	0.05%	190
2016 Q3	$313K	Hold	62,700	–	–	0.06%	183
2016 Q2	$222K	Hold	62,700	–	–	0.04%	200
2016 Q1	$216K	Hold	62,700	–	–	0.04%	199
2015 Q4	$213K	Buy	+62,700	New	+$291K	0.04%	194
2014 Q4	–	Sell	-30,000	Closed	-$278K	–	244
2014 Q3	$278K	Buy	+30,000	New	+$406K	0.06%	187

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Osborn Williams & Donohoe's KIN Position: Q1 2020 in Review

Osborn Williams & Donohoe held its Kindred Biosciences, Inc. (KIN) position steady in Q1 2020 at 62,700 shares worth $251K. The position accounts for 0.03% of the portfolio, ranked #236.

Osborn Williams & Donohoe first reported a position in KIN in Q3 2014 and has held it in 19 quarters since. The position peaked at $875K in Q3 2018. 77 funds tracked by Wall St. Rank hold KIN as of Q1 2020.

Osborn Williams & Donohoe held 62,700 shares of Kindred Biosciences, Inc. worth $251K as of Q1 2020.
Osborn Williams & Donohoe left its Kindred Biosciences, Inc. share count unchanged in Q1 2020.
Kindred Biosciences, Inc. made up 0.03% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #236 holding.
Osborn Williams & Donohoe first reported a position in Kindred Biosciences, Inc. in Q3 2014 and has held it in 19 quarters since.
Osborn Williams & Donohoe's Kindred Biosciences, Inc. position peaked at $875K in Q3 2018.
77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.